Ignite Creation Date:
2024-05-06 @ 8:06 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06255119
Status:
COMPLETED
Last Update Posted:
2024-02-13
First Post:
2023-06-20
Brief Title:
The Feasibility of VR for OUD
Sponsor:
3D Therapy LLC
Organization:
3D Therapy LLC
Study Overview
Official Title:
The Feasibility of 3D Therapy Thrive for Inpatients With Opioid Use Disorder
Status:
COMPLETED
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to evaluate feasibility of a virtual reality software device and measure the effects of the intervention on OUD patient mood tension and cravings as well as the effect of treatment on patient retention to their inpatient detox protocol
Detailed Description:
The primary objective of this study is to evaluate the feasibility and preliminary effectiveness of a novel virtual reality VR based intervention 3D Therapy Thrive 3DTT Inpatient detoxification can improve outcomes for individuals with opioid use disorder OUD however patients often leave treatment early due to mood tension and cravings associated with opioid withdrawal Subjects were recruited from a community inpatient detoxification program and received up to two sessions of 3DTT The patients completed surveys to assess their mood distress cravings and overall satisfaction with the experience Retention was measured by protocol completion as reported by clinic staff independent of the study A group of patients with OUD consecutively admitted to the program comprised a comparison treatment-as-usual TAU group
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None